Ascentage Pharma Group International (36X0.F) Q1 2026 Earnings

24MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.21
-0.12
-0.02
0.07

Details

Expected EPS
-0.180159300912128
Actual EPS
-0.13802738272793602
Surprise EPS
0.04
Surprise Percent
+23.39%

Description

Ascentage Pharma Group International (36X0.F) has reported earnings of -0.13802738272793602 per share for Q1 2026.

0 Comments

Share your thoughts